AzTrials
AzTrials

Retrograde Femoral CatheterismFAP-ECHONCT02878915

Ultrasound-guided Femoral Arterial Puncture for Interventional Neuro-radiology in Children

A study testing Ultrasound guided femoral puncture in people with Retrograde Femoral Catheterism, run by Fondation Ophtalmologique Adolphe de Rothschild at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Using ultrasound to guide vascular catheterism in children is highly recommended for central venous access. It has been proven that central venous line is inserted faster, with fewer attempts and complications. Its interest in central arterial line insertion is less obvious. Read more about this study

Who is it for?
Ages Up to 15 years
Conditions the study is for
Retrograde Femoral Catheterism
What is being tested?
Ultrasound guided femoral puncture
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
149 participants
Where
1 siteFrance
Study dates
17 Nov 2015to 28 Oct 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 15 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • requirement of retrograde femoral arterial catheterism

Who cannot join

  • none

Trial locations and contacts

1 site in 1 country.

France1 site
  • Fondation Ophtalmologique Adolphe de Rothschild

    Paris, 75019

Other trials in France

About this study

Official title: Assessing the Interest of Ultrasound-guided Femoral Arterial Puncture for Interventional Neuro-radiology in Children

Using ultrasound to guide vascular catheterism in children is highly recommended for central venous access. It has been proven that central venous line is inserted faster, with fewer attempts and complications. Its interest in central arterial line insertion is less obvious. It seems to have benefits in adults, both for radial and femoral arterial insertion. But there is no study assessing the interest of ultrasound guided arterial puncture in children,.

Read the detailed description

The use of ultrasound to guide vascular catheterization in children is strongly recommended for central venous vascular access by several international learned societies. In fact, studies have found a reduction in the time it takes to install the central venous line, in the number of attempts and in complications.The benefit of ultrasound to guide catheterization of the arterial network is less documented.

In children, there is an inventory of the traditional approach guided by palpation, in children in intensive care (11). The analysis of 77 femoral puncture attempts in 74 children was carried out. Arterial cannulation was successful in 73 of 77 cases (95%), but only in 60% of cases at the first attempt. Ultrasound guidance appears beneficial in adults for both arterial sites, radial and femoral. On the other hand, in children, unlike radial catheterization, there is no study evaluating the contribution of ultrasound guidance for femoral catheterization.

Being tested
Ultrasound guided femoral puncture

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ultrasound guided femoral punctureDevice

Study groups in NCT02878915
Study groupRoleWhat they receive
Ultrasound guided femoral punctureActive comparatorUltrasound guided femoral puncture
Receives: Device: Ultrasound guided femoral puncture
Palpation guided femoral punctureNo interventionPalpation guided femoral puncture

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Demonstrate that ultrasound guidance improves the success rate at the 1st attempt

    The success rate of catheterisation in the 1st trial will be analysed as the main criterion and compared between the two groups.

    Measured: immediate

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Aug 2016 (estimated)
  2. Study start17 Nov 2015
  3. Primary completion28 Oct 2024
  4. Study completion28 Oct 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
149 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02878915
Sponsor's protocol ID
RBC_2014-34
Acronym
FAP-ECHO
Status last verified
Jan 2026
First submitted
22 Aug 2016
Last updated
22 Jan 2026
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Ultrasound guided femoral puncture in people with Retrograde Femoral Catheterism, run by Fondation Ophtalmologique Adolphe de Rothschild at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Demonstrate that ultrasound guidance improves the success rate at the 1st attempt (time frame: immediate). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in